The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age

Diğer sürümleri göster (1)

A quadrivalent meningococcal vaccine conjugated to CRM197 (MenACWY-CRM197) is immunogenic in young infants. We assessed the memory B-cell and antibody responses after a primary and booster course of MenACWY-CRM197 in children. At 5 months of age, following primary immunisation, serogroup-specific me...

Detaylı Bibliyografya
Asıl Yazarlar:	Blanchard-Rohner, G, Snape, MD, Kelly, D, O'Connor, D, John, T, Clutterbuck, E, Ohene-Kena, B, Klinger, C, Odrljin, T, Pollard, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children
Yazar:: Marzia Monica Giuliani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis serogroups A, C, y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
Yazar:: Hoan Jong Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?
Yazar:: Katharina Schley, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Real-world impact and effectiveness of MenACWY-TT
Yazar:: Rodolfo Villena, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Yazar:: Carr, JP, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
Yazar:: María Gabriela Graña, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
Yazar:: Kelly, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
Yazar:: Timo Vesikari, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
Yazar:: Khatami, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
Yazar:: Khatami, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
Yazar:: J. M. Kemmeren, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany
Yazar:: Sebastian Gruhn, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine (vol 127, pg 134, 2009)
Yazar:: Kelly, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey
Yazar:: Hasan Tezer, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling studyResearch in context
Yazar:: Affan Shoukat, ve diğerleri
Baskı/Yayın Bilgisi: (2025-04-01)

Adolescent and parental decision-making for the MenACWY vaccination: influential predictors and parental-adolescent differences among households in the Netherlands
Yazar:: C. Oostdijk, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults
Yazar:: Javier Díez-Domingo, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.
Yazar:: Kelly, D, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine
Yazar:: Pavitra Keshavan, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
Yazar:: Jessica Presa, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
Yazar:: Clutterbuck, E, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

What school-level and area-level factors influenced HPV and MenACWY vaccine coverage in England in 2016/2017? An ecological study
Yazar:: Nick Andrews, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
Yazar:: Lidia Serra, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children
Yazar:: Markus Knuf, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

Cross-Sectional Study of University Students’ Attitudes to ‘On Campus’ Delivery of COVID-19, MenACWY and MMR Vaccines and Future-Proofing Vaccine Roll-Out Strategies
Yazar:: Adam Webb, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
Yazar:: Cynthia Burman, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
Yazar:: Gary S. Marshall, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Psychosocial and organizational barriers and facilitators of meningococcal vaccination (MenACWY) acceptance among adolescents and parents during the Covid-19 pandemic: a cross-sectional survey
Yazar:: Veja Widdershoven, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Разработка кандидатной субстанции рекомбинантного белка CRM197
Yazar:: E. G. Bogomolova, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

PRODUCTION OF RECOMBINANT PROTEIN CRM197 IN ESCHERICHIA COLI
Yazar:: I. V. Dukhovlinov, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
Yazar:: O. A. Perminova, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

COMPLEXATION OF CURCUMIN WITH BOVINE SERUM ALBUMIN AND DIPHTHERIA TOXOID CRM197
Yazar:: Zhukova D.A., ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Investigating the Deoxyribonuclease Activity of CRM197 with Site-Directed Mutagenesis
Yazar:: Nathalie Bravo-Bautista, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

O:2-CRM(197) conjugates against Salmonella Paratyphi A.
Yazar:: Francesca Micoli, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
Yazar:: Blanchard-Rohner, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Erratum: CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells (Blood (2006) 108 (2642-2647))
Yazar:: Kelly, ve diğerleri
Baskı/Yayın Bilgisi: (2007)